In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Amidst political shifts, President Trump revoked a Biden-era directive aimed at reducing prescription drug costs, raising ...

As the rising cost of insulin continues to make it difficult for so many diabetic patients to receive life-saving care, ...

Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.

Walmart teamed up with drugmaker Novo Nordisk to sell its own brand, called ReliOn insulin, which sells for as little as $25. The pharmaceutical company Novo Nordisk has products sold under the ...

It took another year for the FDA to grant interchangeability status to Rezvoglar, meaning it can be substituted at the pharmacy for Lantus, the brand name insulin glargine, without needing a separate ...

"A Medicare Advantage Part D plan may have covered a particular insulin brand last year but no longer does," she said. "Instead of a $35 monthly cap, you might find your insulin now costs $490 a ...

All Medicare drug plans now offer $35-per-month copays for most insulin brands. Medicare Part D is a Medicare plan offered by private insurance companies for prescription drugs. Based on the most ...

Omnipod 5 remains the first and only tubeless AID system integrated with both brands of CGMs, the company says. Insulet’s Omnipod 5 became the first tubeless, wearable automated insulin delivery ...